COVID-19 Lower Respiratory Infection
12
1
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Follow-up of Covid-19 Long Term Sequelae
Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)
Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients
A Retrospective Study of COVID-19 Treatments
NAC for Attenuation of COVID-19 Symptomatology
Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)
In-patient COVID-19 Study of Intranasal Foralumab
Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients
Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19
Residual Symptoms and the Quality of Life in Individuals Recovered From COVID-19 Infection: A Survey From Pakistan
Osteopathic Manipulative Therapy Effects on Prolonged Post-COVID Olfactory Dysfunction